You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 9, September 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Note
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Clear Cell Odontogenic Carcinoma

Report of a Case and Analysis of the Literature

Margaret Brandwein, MD; Nasser Said-Al-Naief, DDS, MS; Ron Gordon, PhD; Mark Urken, MD

Arch Otolaryngol Head Neck Surg. 2002;128:1089-1095.

Background  Clear cell odontogenic carcinoma (CCOC), which has been described within the past 2 decades, is a rare odontogenic tumor that tends to occur in the mandible of older adults, with a predilection for women. It is potentially aggressive and capable of multiple local recurrences and locoregional and distant metastases.

Objectives  To report the clinicopathologic findings and follow-up of a case of CCOC and to review the literature.

Design  Case report and literature review.

Main Outcome Measurements  Findings from histologic analysis, immunohistochemistry, and electron microscopy.

Results  An 81-year-old woman experienced 3 locoregional recurrences within 21 months of initial therapy. She is presently disease free, 4.5 years after initial resection, having received multiple resections and adjuvant radiotherapy.

Conclusions  The diagnosis of CCOC must be considered in the differential diagnosis of jaw tumors with a clear cell component. For these tumors, resection with negative margins is the treatment of choice because more conservative surgery (eg, curettage) inevitably results in recurrence and/or metastasis. Adjuvant radiotherapy is a rational option for tumors that have eroded cortex.


From the Departments of Pathology (Drs Brandwein, Said-Al-Naief, and Gordon) and Otolaryngology (Drs Brandwein and Urken), Mount Sinai Medical Center, New York, NY. Dr Said-Al-Naief is currently at the Department of Pathology, University of Alabama, Birmingham.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.